Canaan Partners led a $16.5m series D round in Apnimed.

Synopsis

Canaan Partners, a venture capital firm, led a $16.5m series D round in Apnimed, a clinical-stage pharmaceutical company, with participation from Alpha Wave Ventures and other institutional investors.

Principals

target

APNIMED

bidder

Canaan Partners

Show Details & Financials

Did you work on this deal?

Claim Deal

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Claim Deal

Market Context

cooley

HQ - Palo Alto

legal advisors

bidder

2363

Deals

£ 715.00 B

Total Value